| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
92,000,000 |
| Market
Cap: |
236.44(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.235 - $5.82 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Absci is a drug and target discovery company. Co. develops an integrated drug creation platform by merging deep learning artificial intelligence (AI) and synthetic biology. The integrated drug creation platform enables target identification, and parallel discovery of biologics and with production cell lines by incorporating biodiversity, high-throughput single cell single cell assays, and deep learning AI models. Co. uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and Co. learns from the data it generates. Co.'s designs are AI-informed and its technology platform is scaffold-agnostic.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
222,222 |
| Total Buy Value |
$0 |
$0 |
$0 |
$999,999 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
3,119,859 |
| Total Sell Value |
$0 |
$0 |
$0 |
$13,738,892 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pangalos Menelas N |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
18,175 |
|
- |
|
| Sirosh Joseph |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
23,320 |
|
- |
|
| Mcginnis Karen K |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
38,320 |
|
- |
|
| Rabinovitsj Daniel A |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
23,320 |
|
- |
|
| Houten Frans Van |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
23,320 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2025-05-31 |
4 |
D |
$2.65 |
$13,764 |
D/D |
(5,194) |
418,060 |
|
- |
|
| Bedrick Todd |
SVP, CAO |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
29,700 |
167,827 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
81,500 |
423,254 |
|
- |
|
| Mcclain Sean |
Chief Executive Officer |
• • – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
190,200 |
8,384,621 |
|
- |
|
| Walker Shelby J. |
Chief Legal Officer |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
59,300 |
59,300 |
|
- |
|
| Busch Andreas |
Chief Innovation Officer |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,700 |
277,264 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2025-02-28 |
4 |
D |
$4.04 |
$21,085 |
D/D |
(5,219) |
341,754 |
|
- |
|
| Busch Andreas |
Chief Innovation Officer |
• – – |
2025-02-01 |
4 |
D |
$3.71 |
$5,450 |
D/D |
(1,469) |
253,564 |
|
- |
|
| Bedrick Todd |
SVP, CAO |
• – – |
2025-02-01 |
4 |
D |
$3.71 |
$9,757 |
D/D |
(2,630) |
138,127 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2025-02-01 |
4 |
D |
$3.71 |
$42,914 |
D/D |
(11,567) |
346,973 |
|
- |
|
| Mcclain Sean |
Chief Executive Officer |
• • – |
2025-02-01 |
4 |
D |
$3.71 |
$63,037 |
D/D |
(16,991) |
8,194,421 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2024-11-30 |
4 |
D |
$3.05 |
$15,842 |
D/D |
(5,194) |
358,540 |
|
- |
|
| Mcclain Sean |
Chief Executive Officer |
• • – |
2024-10-12 |
4 |
D |
$4.07 |
$59,190 |
D/D |
(14,543) |
8,211,412 |
|
- |
|
| Busch Andreas |
Chief Innovation Officer |
• – – |
2024-10-12 |
4 |
D |
$4.07 |
$12,584 |
D/D |
(3,092) |
255,033 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2024-10-12 |
4 |
D |
$4.07 |
$985 |
D/D |
(242) |
363,734 |
|
- |
|
| Bedrick Todd |
SVP, CAO |
• – – |
2024-10-12 |
4 |
D |
$4.07 |
$63,516 |
D/D |
(15,606) |
139,064 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2024-08-31 |
4 |
D |
$4.40 |
$91,410 |
D/D |
(20,775) |
363,976 |
|
- |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2024-06-13 |
4 |
S |
$4.98 |
$98,892 |
D/D |
(19,859) |
384,751 |
|
6% |
|
| Jonasson Zachariah |
CFO / CBO |
• – – |
2024-06-13 |
4 |
OE |
$3.39 |
$97,293 |
D/D |
28,700 |
404,610 |
|
- |
|
| Rabinovitsj Daniel A |
Director |
– • – |
2024-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,820 |
8,820 |
|
- |
|
62 Records found
|
|
Page 1 of 3 |
|
|
0.05 (1.91%) 
